Supernus Pharmaceuticals reported $130.38M in Gross Profit on Sales for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Gross Profit On Sales Change
Abbott ABT:US $ 6505M 1225M
Adamas Pharmaceuticals ADMS:US 25.32M 3.88M
Aerie Pharmaceuticals AERI:US $ 21.41M 0.41M
Ani Pharmaceuticals ANIP:US $ 27.65M 1.34M
Aphria Inc APH:CN C$ -7278000 20.68M
Aurora Cannabis Inc ACB:CN 14.1M 75.17M
Bristol Myers Squibb BMY:US $ 9333M 81M
Canopy Growth Corp WEED:CN C$ -71140000 98.38M
Corcept Therapeutics CORT:US $ 94.86M 4.65M
Eisai 4523:JP Y 122837M 36807M
Eli Lilly And LLY:US $ 5342M 555.1M
Endo International Ordinary Shares ENDP:US $ 474.91M 74.51M
Gw Pharmaceuticals GWPH:US $ 140.66M 2.86M
Horizon Pharma HZNP:US $ 785.35M 153.8M
JAZZ PHA JAZZ:US $ 692.89M 60.27M
Lannett LCI:US $ 16.52M 6.14M
Pacira Pharmaceuticals PCRX:US $ 93.07M 7.27M
Perrigo Ordinary Shares PRGO:US $ 336.4M 12.6M
Pfizer PFE:US $ 14163M 2178M
Revance Therapeutics RVNC:US $ 13.86M 481K
Supernus Pharmaceuticals SUPN:US $ 130.38M 14.08M
Teva Pharmaceutical Industries TEVA:US $ 1898M 25M
United Therapeutics UTHR:US $ 417M 7.7M
Xeris Pharmaceuticals Inc XERS:US $ 7.84M 2.32M